Nicaise, Edouard
Feldman, Adam S.
Gusev, Andrew
Yu, Alice
Nimmagadda, Naren
Wszolek, Matthew F.
McGovern, Francis
Blute, Michael L.
Dahl, Douglas M.
Article History
Received: 12 August 2023
Accepted: 1 February 2024
First Online: 12 March 2024
Declarations
:
: All methods were carried out in accordance with the Massachusetts General Hospital Institutional Review Board (IRB). The MGH IRB ethical approval was received to retrospectively review patient data from the institutional kidney cancer database. Informed consent was not required for our retrospective review according to the MGH IRB given the retrospective nature of the study protocol. In addition, no protected health information was reported, and the exported dataset from which we worked, was entirely de-identified.
: Not applicable.
: All authors do not have any competing interests to disclose.